Edi Levi
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Cell death mechanisms and regulation 7
- Oncology 34
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 7
- PARP inhibition in cancer therapy 6
- Co-authors
- Adhip P.N. Majumdar (24 shared papers)Fazlul H. Sarkar (7 shared papers)Marshall E. Kadin (10 shared papers)Yingjie Yu (13 shared papers)Volkan Adsay (9 shared papers)Olca Baştürk (6 shared papers)David S. Klimstra (2 shared papers)Lulu Farhana (8 shared papers)
- Journals
- PLoS ONE (5 papers)Oncotarget (3 papers)Biochemical and Biophysical Research Communications (3 papers)Endoscopy (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesTürkiyeSaudi Arabia
In The Last Decade
Edi Levi
104 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 112
- Oncology 931
- Dermatology 299
- Cancer Research 447
- Molecular Medicine 157
- Pathology and Forensic Medicine 354
Countries citing papers authored by Edi Levi
This map shows the geographic impact of Edi Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edi Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edi Levi more than expected).
Fields of papers citing papers by Edi Levi
This network shows the impact of papers produced by Edi Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edi Levi. The network helps show where Edi Levi may publish in the future.
Co-authors
The 25 scholars most cited alongside Edi Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 345 | |
| 2 | 2009 | 159 | |
| 3 | 2015 | 138 | |
| 4 | 2012 | 134 | |
| 5 | 2006 | 115 | |
| 6 | 2004 | 106 | |
| 7 | 1999 | 103 | |
| 8 | 2014 | 103 | |
| 9 | 2000 | 95 | |
| 10 | 2008 | 69 | |
| 11 | 2005 | 67 | |
| 12 | 2006 | 64 | |
| 13 | 2002 | 63 | |
| 14 | 2008 | 51 | |
| 15 | 2006 | 48 | |
| 16 | 2015 | 45 | |
| 17 | 2018 | 45 | |
| 18 | 1999 | 43 | |
| 19 | 2011 | 42 | |
| 20 | 2002 | 39 |
About Edi Levi
Edi Levi is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 104 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Cutaneous lymphoproliferative disorders research (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cell death mechanisms and regulation (7 papers), Pancreatic function and diabetes (6 papers), PARP inhibition in cancer therapy (6 papers), Blood properties and coagulation (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (931 citations), Dermatology (299 citations), Cancer Research (447 citations), Molecular Medicine (157 citations) and Pathology and Forensic Medicine (354 citations). Edi Levi has collaborated with scholars based in United States, Türkiye and Saudi Arabia. Frequent co-authors include Adhip P.N. Majumdar, Fazlul H. Sarkar, Marshall E. Kadin, Yingjie Yu, Volkan Adsay, Olca Baştürk, David S. Klimstra, Lulu Farhana, Pratima Nangia‐Makker and Jeanette D. Cheng. Their work appears in journals such as PLoS ONE, Oncotarget, Biochemical and Biophysical Research Communications, Endoscopy and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.